ReviewDiabetes, obesity & metabolism2015

Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes.

M D SharmaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.